0.36
+0.0015(+0.42%)
Currency In USD
| Previous Close | 0.36 |
| Open | 0.36 |
| Day High | 0.37 |
| Day Low | 0.35 |
| 52-Week High | 0.98 |
| 52-Week Low | 0.26 |
| Volume | 43,149 |
| Average Volume | 568,298 |
| Market Cap | 80.76M |
| PE | -1.53 |
| EPS | -0.23 |
| Moving Average 50 Days | 0.37 |
| Moving Average 200 Days | 0.47 |
| Change | -0.01 |
If you invested $1000 in Vaxart, Inc. (VXRT) 10 years ago, it would be worth $16.04 as of October 24, 2025 at a share price of $0.353. Whereas If you bought $1000 worth of Vaxart, Inc. (VXRT) shares 5 years ago, it would be worth $67.2 as of October 24, 2025 at a share price of $0.353.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
GlobeNewswire Inc.
Oct 20, 2025 12:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today anno
Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025
GlobeNewswire Inc.
Oct 08, 2025 12:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery pla
Vaxart Announces Withdrawal of Reverse Stock Split Proposal
GlobeNewswire Inc.
Sep 19, 2025 12:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery pl